PBRM1 Inactivation Promotes Upregulation of Human Endogenous Retroviruses in a HIF-Dependent Manner

Clear cell renal cell carcinoma (ccRCC) is considered an immunotherapy-responsive disease; however, the reasons for this remain unclear. Studies have variably implicated PBRM1 mutations as a predictive biomarker of immune checkpoint blockade (ICB) response, and separate studies demonstrate that expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Mi, Leung, Janet Y., Gessner, Kathryn H., Hepperla, Austin J., Simon, Jeremy M., Davis, Ian J., Kim, William Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Priority Brief
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898299/
https://www.ncbi.nlm.nih.gov/pubmed/35013001
http://dx.doi.org/10.1158/2326-6066.CIR-21-0480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898299/
https://www.ncbi.nlm.nih.gov/pubmed/35013001
http://dx.doi.org/10.1158/2326-6066.CIR-21-0480

Ejemplares similares